Retroperitoneal liposarcoma (RPLS) is a malignant tumor that originates from primitive mesenchymal tissues. This tumor has a relatively low incidence but an extremely high local recurrence rate, especially in cases with multiple recurrences and extensive invasion of surrounding tissues. The clinical management is quite challenging. This article reports the case of a 50-year-old male patient with a giant RPLS. The patient underwent three surgeries successively. The tumor involved the colon and the psoas muscle fascia, wrapped around the branches of the lumbar plexus nerve. After combined resection of the nerve branches, there was a brief sensory and motor dysfunction in the left lower limb. Based on this case and related literature, this article summarized the diagnosis, pathological characteristics and treatment plans of RPLS, in order to provide a reference for the clinical diagnosis and treatment of RPLS.
1. WangX,SongX,SongQ,et al.Recurrent retroperitoneal liposarcoma with multiple surgeries: a case report[J].Front Oncol,2024,14:1363055.DOI:10.3389/fonc.2024.1363055.
2. TuX,ZhuangX,HuangC.Retroperitoneal dedifferentiated liposarcoma with colon infiltration: a case report and literature review[J].Front Oncol,2025,15:1724071.DOI:10.3389/fonc.2025.1724071.
3. SantangeloA,FernicolaA,SantangeloD,et al.Dark topics on giant retroperitoneal liposarcoma: a systematic review of 157 cases[J].Cancers (Basel),2025,17(5):740.DOI:10.3390/cancers17050740.
4. ChengSH,HuangYS,LeeHH,et al.Case report and literature review: conversion surgery for initially unresectable huge retroperitoneal liposarcoma after preoperative radiotherapy[J].Front Oncol,2023,12:1096411.DOI:10.3389/fonc.2022.1096411.
5. SiegelRL,MillerKD,JemalA.Cancer statistics, 2018[J].CA Cancer J Clin,2018,68(1):7-30.DOI:10.3322/caac.21442.
6. SbaragliaM,BellanE,Dei TosAP.The 2020 WHO classification of soft tissue tumours: news and perspectives[J].Pathologica,2021,113(2):70-84.DOI:10.32074/1591-951X-213.
7. SanomachiT,IshikiH.Classifying and grading liposarcoma by CT[J].Lancet Oncol,2024,25(2):e53.DOI:10.1016/S1470-2045(24)00005-6.
8. Marjiyeh-AwwadR,MansourS,KhuriS.Giant retroperitoneal liposarcoma: correlation between size and risk for recurrence[J].World J Oncol,2022,13(5):244-248.DOI:10.14740/wjon1528.
9. MansfieldSA,PollockRE,GrignolVP.Surgery for abdominal well-differentiated liposarcoma[J].Curr Treat Options Oncol,2018,19(1):1.DOI:10.1007/s11864-018-0520-6.
10. XiaoJ,LiuJ,ChenM,et al.Diagnosis and prognosis of retroperitoneal liposarcoma: a single Asian center cohort of 57 cases[J].J Oncol,2021,2021:7594027.DOI:10.1155/2021/7594027.
11. TeniolaO,WangKY,WangWL,et al.Imaging of liposarcomas for clinicians: characteristic features and differential considerations[J].J Surg Oncol,2018,117(6):1195-1203.DOI:10.1002/jso.24949.
12. YangL,ChenS,LuoP,et al.Liposarcoma: advances in cellular and molecular genetics alterations and corresponding clinical treatment[J].J Cancer,2020,11(1):100-107.DOI:10.7150/jca.36380.
13. 黄晓东,李沛雨,卢灿荣,等.腹膜后脂肪肉瘤切除术后免疫组化标记物MDM2、CDK4、Ki-67与其预后的关系[J].解放军医学院学报,2016,37(1):34-38.HuangXD,LiPY,LuCR,et al.Prognostic factors of immunohistochemical markers MDM2, CDK4, Ki-67 in retroperitoneal liposarcoma[J].Academic Journal of Chinese PLA Medical School,2016,37(1):34-38.DOI:10.3969/j.issn.2095-5227.2016.01.010.
14. 粟杰,肖何,李梦侠,等.MDM2在去分化脂肪肉瘤中的表达及临床意义[J].肿瘤学杂志,2023,29(3):226-231.SuJ,XiaoH,LiMX,et al.Expression and clinical significance of MDM2 in dedifferentiated liposarcoma[J].Journal of Chinese Oncology,2023,29(3):226-231.DOI:10.11735/j.issn.1671-170X.2023.03.B010.
15. MS A,K C,BhargavanRV,et al.An overview on liposarcoma subtypes: genetic alterations and recent advances in therapeutic strategies[J].J Mol Histol,2024,55(3):227-240.DOI:10.1007/s10735-024-10195-4.
16. 霍明科,韩广森,赵玉洲,等.腹膜后脂肪肉瘤亚型转换的相关因素及预后分析[J].中国肿瘤临床,2016,43(8):334-338.HuoMK,HanGS,ZhaoYZ,et al.Analysis of prognostic factors and the related factors on subtype transformation of retroperitoneal liposarcoma[J].Chinese Journal of Clinical Oncology,2016,43(8):334-338.DOI:10.3969/j.issn.1000-8179.2016.08.310.
17. JavedA,HaghshenasJ,SholemS,et al.Rare presentations of rapidly growing liposarcomas[J].J Coll Physicians Surg Pak,2021,31(8):982-985.DOI:10.29271/jcpsp.2021.08.982.
18. 李洪明,冯晓创,林佳鑫,等.巨大腹膜后肿瘤的术前评估和手术策略[J].结直肠肛门外科,2022,28(2):103-108.LiHM,FengXC,LinJX,et al.Preoperative evaluation and surgical strategy for giant retroperitoneal tumors[J].Journal of Colorectal & Anal Surgery,2022,28(2):103-108.DOI:10.19668/j.cnki.issn1674-0491.2022.02.001.
19. DengH,CaoB,CuiH,et al.Clinical analysis of 5-year survival and recurrence in giant retroperitoneal liposarcoma after surgery[J].Chin Med J (Engl),2023,136(3):373-375.DOI:10.1097/CM9.0000000000002405.
20. TsengWW,SwallowCJ,StraussDC,et al.Management of locally recurrent retroperitoneal sarcoma in the adult: an updated consensus approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group[J].Ann Surg Oncol,2022,29(12):7335-7348.DOI:10.1245/s10434-022-11864-y.
21. LawlessA,ZhouDD,McDonoughJ,et al.The role of radiation therapy in the management of primary retroperitoneal sarcoma: a systematic review and clinical practice guidelines from the Australia and New Zealand Sarcoma Association[J].Cancer Treat Rev,2023,120:102620.DOI:10.1016/j.ctrv.2023.102620.
22. DaiN,YuanJ,WangX,et al.Giant intra-abdominal tumor, compatible with liposarcoma: a case report and literature review[J].Am J Case Rep,2025,26:e948952.DOI:10.12659/AJCR.948952.
23. ChenX,ChenJ,CananziFCM,et al.Prophylactic ureteral catheter placement appears to reduce intraoperative ureteric injury during resection of primary retroperitoneal liposarcoma[J].Technol Cancer Res Treat,2022,21:15330338221087831.DOI:10.1177/15330338221087831.
24. Forero-EscobedoS,Gonzalez-RodriguezSM,Ramírez-RincónJA,et al.Giant retroperitoneal liposarcoma with colonic infiltration as a cause of gastrointestinal bleeding: case report and literature review[J].Int J Surg Case Rep,2025,129:111142.DOI:10.1016/j.ijscr.2025.111142.
25. ShafirM,HollandJF,CohenB,et al.Radical retroperitoneal tumor surgery with resection of the psoas major muscle[J].Cancer,1985,56(4):929-933.DOI:10.1002/1097-0142(19850815)56:4<929::aid-cncr2820560438>3.0.co;2-7.
26. MunozP,Bretcha-BoixP,ArtigasV,et al.Surgical principles of primary retroperitoneal sarcoma in the era of personalized treatment: a review of the frontline extended surgery[J].Cancers (Basel),2022,14(17):4091.DOI:10.3390/cancers14174091.
27. 热孜万古丽·乌斯曼,杜丹阳,斯坎德尔·努尔买买提,等.腹膜后巨大脂肪肉瘤1例报道并文献复习[J].新疆医学,2021,51(8):967-969, 951.RZWGLWusiman,DuDY,NuermaimaitiSKDE,et al.A case report of giant retroperitoneal liposarcoma and literature review[J].Xinjiang Medical Journal,2021,51(8):967-969, 951.DOI:10.27023/j.cnki.1001-5183.2021.08.030.